<DOC>
	<DOCNO>NCT00264381</DOCNO>
	<brief_summary>The purpose study test hypothesis Fragmin ( dalteparin sodium ) subcutaneously daily 7 day effective Ibuprofen give orally three time daily 7 day treatment superficial thrombophlebitis ( STP ) .</brief_summary>
	<brief_title>Management Superficial Thrombophlebitis</brief_title>
	<detailed_description>Superficial thrombophlebitis common problem think affect 20 % patient varicose vein . In absence treatment , STP may cause great morbidity extension thrombus deep venous system resultant risk pulmonary embolism . Current standard therapy STP consist local heat , elevation extremity , non-steroidal anti-inflammatory medication . However , study date adequately evaluate effectiveness therapy despite persistence recurrence symptom STP many patient . The purpose study document outcome patient objectively document STP treat NSAID therapy ( standard care ) verse treated low-molecular weight heparin ( dalteparin sodium ) accord pre-defined treatment regimen . All patient document upper low STP screen . Each complete baseline risk factor assessment . All patient randomize one two treatment group : ( ) Experimental group receive Fragmin ( dalteparin ) fix dose subcutaneously daily 7 day ( b ) Control group receive ibuprofen 800mg give orally three time daily 7 day . All patient receive study drug period 1-2 week reassessment STP ultrasound . All patient participate period 3 month follow visit 7-9 , 14-16 day , 1,3 month .</detailed_description>
	<mesh_term>Thrombophlebitis</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Patients confirm upper low extremity superficial thrombophlebitis ultrasound image Active , clinically significant bleed Known hypersensitivity NSAIDS , heparin derivative Currently pregnant &lt; 1 week postpartum Acquired bleeding diathesis Known inherit bleed disorder Renal failure Extremes weight unable return repeat diagnostic test followup visit Concurrent deepvein thrombosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Superficial Thrombophlebitis</keyword>
	<keyword>STP</keyword>
	<keyword>Fragmin</keyword>
	<keyword>Ibuprofen</keyword>
	<keyword>Superficial Thrombus</keyword>
	<keyword>Superficial Phlebitis</keyword>
	<keyword>phlebitis</keyword>
</DOC>